LEADER 00939nam0-2200325---450-
001 990009198370403321
005 20100615112524.0
010   $a0226520277
035   $a000919837
035   $aFED01000919837
035   $a(Aleph)000919837FED01
035   $a000919837
100   $a20100615d1976----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $aa-------101yy
200 1 $aAntivirals with clinical potential$fedited by Thomas C. Merigan
210   $aChicago ; London$cUniversity of Chicago Press$d1976
215   $a292 p.$cill.$d29 cm
610 0 $aMalattie virali
676   $a616.92
702  1$aMerigan,$bThomas C.
712 12$aNational Institute of Allergy and Infectious Diseases
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990009198370403321
952   $aIG 17 L 15$b1583$fDMIGI
959   $aDMIGI
996   $aAntivirals with clinical potential$9775096
997   $aUNINA